162 related articles for article (PubMed ID: 8336750)
21. A population-based case-control study of the Arg399Gln polymorphism in DNA repair gene XRCC1 and risk of breast cancer.
Shu XO; Cai Q; Gao YT; Wen W; Jin F; Zheng W
Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1462-7. PubMed ID: 14693738
[TBL] [Abstract][Full Text] [Related]
22. Allelic variation of reporter gene activation by the HRAS1 minisatellite.
Green M; Krontiris TG
Genomics; 1993 Aug; 17(2):429-34. PubMed ID: 8406494
[TBL] [Abstract][Full Text] [Related]
23. Association of rare alleles of the Harvey ras protooncogene locus with lung cancer.
Sugimura H; Caporaso NE; Modali RV; Hoover RN; Resau JH; Trump BF; Longergan JA; Krontiris TG; Mann DL; Weston A
Cancer Res; 1990 Mar; 50(6):1857-62. PubMed ID: 2407346
[TBL] [Abstract][Full Text] [Related]
24. The CAG and GGC microsatellites of the androgen receptor gene are in linkage disequilibrium in men with prostate cancer.
Irvine RA; Yu MC; Ross RK; Coetzee GA
Cancer Res; 1995 May; 55(9):1937-40. PubMed ID: 7728763
[TBL] [Abstract][Full Text] [Related]
25. DNA repair gene polymorphisms and risk of second primary neoplasms and mortality in oral cancer patients.
Gal TJ; Huang WY; Chen C; Hayes RB; Schwartz SM
Laryngoscope; 2005 Dec; 115(12):2221-31. PubMed ID: 16369171
[TBL] [Abstract][Full Text] [Related]
26. Association of a functional tandem repeats in the downstream of human telomerase gene and lung cancer.
Wang L; Soria JC; Chang YS; Lee HY; Wei Q; Mao L
Oncogene; 2003 Oct; 22(46):7123-9. PubMed ID: 14562040
[TBL] [Abstract][Full Text] [Related]
27. HRAS1 rare minisatellite alleles and breast cancer in Australian women under age forty years.
Firgaira FA; Seshadri R; McEvoy CR; Dite GS; Giles GG; McCredie MR; Southey MC; Venter DJ; Hopper JL
J Natl Cancer Inst; 1999 Dec; 91(24):2107-11. PubMed ID: 10601382
[TBL] [Abstract][Full Text] [Related]
28. Clarifying the PROGINS allele association in ovarian and breast cancer risk: a haplotype-based analysis.
Pearce CL; Hirschhorn JN; Wu AH; Burtt NP; Stram DO; Young S; Kolonel LN; Henderson BE; Altshuler D; Pike MC
J Natl Cancer Inst; 2005 Jan; 97(1):51-9. PubMed ID: 15632380
[TBL] [Abstract][Full Text] [Related]
29. [An increased frequency of allele A6 of the proto-oncogene HRAS1 in cancer patients].
Nikiforova IF; Pluzhnikova GF; Serova OM; Kniazev PG
Vopr Onkol; 1991; 37(6):700-5. PubMed ID: 1843147
[TBL] [Abstract][Full Text] [Related]
30. Susceptibility for breast cancer in young patients with short rare minisatellite alleles of BORIS.
Yoon SL; Kim DC; Cho SH; Lee SY; Chu IS; Heo J; Leem SH
BMB Rep; 2010 Oct; 43(10):698-703. PubMed ID: 21034534
[TBL] [Abstract][Full Text] [Related]
31. Skewed X chromosome inactivation and breast and ovarian cancer status: evidence for X-linked modifiers of BRCA1.
Lose F; Duffy DL; Kay GF; Kedda MA; Spurdle AB; ;
J Natl Cancer Inst; 2008 Nov; 100(21):1519-29. PubMed ID: 18957670
[TBL] [Abstract][Full Text] [Related]
32. hOGG1 Ser326Cys polymorphism and risk of lung cancer by histological type.
Okasaka T; Matsuo K; Suzuki T; Ito H; Hosono S; Kawase T; Watanabe M; Yatabe Y; Hida T; Mitsudomi T; Tanaka H; Yokoi K; Tajima K
J Hum Genet; 2009 Dec; 54(12):739-45. PubMed ID: 19881468
[TBL] [Abstract][Full Text] [Related]
33. HRAS1 variable number of tandem repeats polymorphism and risk of bladder cancer.
van Gils CH; Conway K; Li Y; Taylor JA
Int J Cancer; 2002 Aug; 100(4):414-8. PubMed ID: 12115522
[TBL] [Abstract][Full Text] [Related]
34. An association between the allele coding for a low activity variant of catechol-O-methyltransferase and the risk for breast cancer.
Lavigne JA; Helzlsouer KJ; Huang HY; Strickland PT; Bell DA; Selmin O; Watson MA; Hoffman S; Comstock GW; Yager JD
Cancer Res; 1997 Dec; 57(24):5493-7. PubMed ID: 9407957
[TBL] [Abstract][Full Text] [Related]
35. Impact of the cyclin D1 A870G polymorphism on susceptibility to sporadic colorectal cancer in Taiwan.
Huang WS; Tang R; Lin PY; Changchien CR; Chen JS; Chiang JM; Yeh CY; Wang JY; Hsieh LL
Dis Colon Rectum; 2006 May; 49(5):602-8. PubMed ID: 16552496
[TBL] [Abstract][Full Text] [Related]
36. Linkage between polymorphisms in the prostate specific antigen ARE1 gene region, prostate cancer risk, and circulating tumor cells.
Medeiros R; Morais A; Vasconcelos A; Costa S; Pinto D; Oliveira J; Carvalho R; Lopes C
Prostate; 2002 Sep; 53(1):88-94. PubMed ID: 12210484
[TBL] [Abstract][Full Text] [Related]
37. MTHFR polymorphisms as prognostic factors in sporadic colorectal cancer.
Osian G; Procopciuc L; Vlad L
J Gastrointestin Liver Dis; 2007 Sep; 16(3):251-6. PubMed ID: 17925917
[TBL] [Abstract][Full Text] [Related]
38. Association of p53 polymorphisms with breast cancer: a case-control study in Slovak population.
Franeková M; Zúbor P; Stanclová A; Dussan CA; Bohusová T; Galo S; Dobrota D; Kajo K; Péc M; Racay P
Neoplasma; 2007; 54(2):155-61. PubMed ID: 17319790
[TBL] [Abstract][Full Text] [Related]
39. The androgen receptor CAG repeat polymorphism and risk of breast cancer in the Nurses' Health Study.
Haiman CA; Brown M; Hankinson SE; Spiegelman D; Colditz GA; Willett WC; Kantoff PW; Hunter DJ
Cancer Res; 2002 Feb; 62(4):1045-9. PubMed ID: 11861380
[TBL] [Abstract][Full Text] [Related]
40. Polymorphic markers in the SRD5A2 gene and prostate cancer risk: a population-based case-control study.
Hsing AW; Chen C; Chokkalingam AP; Gao YT; Dightman DA; Nguyen HT; Deng J; Cheng J; Sesterhenn IA; Mostofi FK; Stanczyk FZ; Reichardt JK
Cancer Epidemiol Biomarkers Prev; 2001 Oct; 10(10):1077-82. PubMed ID: 11588134
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
